Literature DB >> 3978582

Factors influencing survival in carcinoma of the ovary. Study from a well-defined Swedish population.

N Einhorn, B Nilsson, K Sjövall.   

Abstract

Prognostic factors were studied in 770 cases of carcinoma of the ovary treated at Radiumhemmet during 1974 to 1979. Centralization of the treatment in a well-defined population with complete follow-up permits a nonselective study of the disease. The analysis was made separately for early and late stages. For the early cases, histology and grading were the most dominant prognostic factors. For the most advanced cases successful surgical treatment, either primary or secondary, showed significant relation to survival. Successful secondary surgery could be achieved in twice as many cases where radiotherapy was included in the treatment. Even for the advanced cases, the stage but not the histology was of prognostic significance. The major difficulties in evaluating treatment of ovarian cancer, especially in advanced cases, are associated with the multiplicity of sites of the disease and the prognostic factors that may contribute independently to the outcome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978582     DOI: 10.1002/1097-0142(19850501)55:9<2019::aid-cncr2820550932>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Imaging of ovarian cancer with radiolabelled monoclonal antibodies.

Authors:  D L van Kranenburg; M J van Kroonenburgh; J B Trimbos; G J Fleuren; E K Pauwels
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

Review 2.  Treatment of ovarian cancer: the state of the art.

Authors:  N Einhorn
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

3.  Can you screen for ovarian cancer?

Authors:  M L Hicks; G Parham
Journal:  J Natl Med Assoc       Date:  1995-02       Impact factor: 1.798

4.  Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin.

Authors:  G Paganelli; C Belloni; P Magnani; F Zito; A Pasini; I Sassi; M Meroni; M Mariani; M Vignali; A G Siccardi
Journal:  Eur J Nucl Med       Date:  1992

5.  What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.

Authors:  Bunja J Rungruang; Austin Miller; Thomas C Krivak; Neil S Horowitz; Noah Rodriguez; Chad A Hamilton; Floor J Backes; Linda F Carson; Michael Friedlander; David G Mutch; Michael J Goodheart; Krishnansu S Tewari; Robert M Wenham; Michael A Bookman; G Larry Maxwell; Scott D Richard
Journal:  Cancer       Date:  2016-11-16       Impact factor: 6.860

6.  Prognostic importance of peritoneal lesion-to-primary tumour standardized uptake value ratio in advanced serous epithelial ovarian cancer.

Authors:  Hyun Hoon Chung; Jae-Weon Kim; Noh-Hyun Park; Yong Sang Song; Gi Jeong Cheon
Journal:  Eur Radiol       Date:  2017-12-19       Impact factor: 5.315

7.  Survival and prognostic factors of early ovarian cancer.

Authors:  A Villa; F Parazzini; S Acerboni; P Guarnerio; G Bolis
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

8.  The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.

Authors:  Charlotte E Joslin; Katherine C Brewer; Faith G Davis; Kent Hoskins; Caryn E Peterson; Heather A Pauls
Journal:  Gynecol Oncol       Date:  2014-08-28       Impact factor: 5.482

9.  Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer.

Authors:  Su-Jin Baek; Jeong-Yeol Park; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2008-12-29       Impact factor: 4.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.